The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2017 | Looking forward to the 17th iwCLL meeting in New York, 12–15 May 2017
Peter Hillmen from St. James’ University Hospital, Leeds, UK introduces the 17th International Workshop on chronic lymphocytic leukemia (iwCLL), which will be held in New York between 12 and 15 May, 2017. Themes covered will span early CLL through to relapsed/refractory disease – new treatments, guidelines and major clinical trials. Smaller, more intimate meetings like this one give us the chance to spend a lot of time talking about CLL compared with larger meetings that focus on a wide range of haematological malignancies. Early registration closes 16 December and abstracts will be available early in the new year. A young investigator meeting will take place the day before and will offer an opportunity for new relationships and collaborations to be developed. To find out more visit http://www.iwcll2017.org/ and stay tuned at www.vjhemonc.com for updates and coverage.
